Barclays’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $909K | Buy |
99,618
+40,031
| +67% | +$365K | ﹤0.01% | 2717 |
|
|
2025
Q1 | $474K | Sell |
59,587
-35,861
| -38% | -$285K | ﹤0.01% | 2873 |
|
|
2024
Q4 | $518K | Sell |
95,448
-32,341
| -25% | -$176K | ﹤0.01% | 3031 |
|
|
2024
Q3 | $923K | Buy |
127,789
+49,171
| +63% | +$355K | ﹤0.01% | 2665 |
|
|
2024
Q2 | $853K | Buy |
78,618
+704
| +0.9% | +$7.64K | ﹤0.01% | 2204 |
|
|
2024
Q1 | $1.46M | Sell |
77,914
-119,146
| -60% | -$2.23M | ﹤0.01% | 2147 |
|
|
2023
Q4 | $4.27M | Sell |
197,060
-9,353
| -5% | -$203K | ﹤0.01% | 1617 |
|
|
2023
Q3 | $4.25M | Buy |
206,413
+62,454
| +43% | +$1.29M | ﹤0.01% | 1224 |
|
|
2023
Q2 | $6.77M | Sell |
143,959
-3,103
| -2% | -$146K | ﹤0.01% | 1066 |
|
|
2023
Q1 | $6.17M | Buy |
147,062
+50,739
| +53% | +$2.13M | ﹤0.01% | 987 |
|
|
2022
Q4 | $3.67M | Sell |
96,323
-9,243
| -9% | -$352K | ﹤0.01% | 1287 |
|
|
2022
Q3 | $4.13M | Buy |
105,566
+99,159
| +1,548% | +$3.88M | ﹤0.01% | 1206 |
|
|
2022
Q2 | $206K | Sell |
6,407
-30,890
| -83% | -$993K | ﹤0.01% | 3106 |
|
|
2022
Q1 | $1.24M | Sell |
37,297
-26,055
| -41% | -$863K | ﹤0.01% | 2145 |
|
|
2021
Q4 | $2.7M | Buy |
63,352
+12,885
| +26% | +$548K | ﹤0.01% | 1632 |
|
|
2021
Q3 | $2.24M | Buy |
50,467
+22,157
| +78% | +$982K | ﹤0.01% | 1782 |
|
|
2021
Q2 | $1.61M | Sell |
28,310
-36,222
| -56% | -$2.06M | ﹤0.01% | 1849 |
|
|
2021
Q1 | $4.83M | Buy |
64,532
+60,523
| +1,510% | +$4.53M | ﹤0.01% | 1214 |
|
|
2020
Q4 | $347K | Buy |
4,009
+203
| +5% | +$17.6K | ﹤0.01% | 2487 |
|
|
2020
Q3 | $233K | Sell |
3,806
-14,050
| -79% | -$860K | ﹤0.01% | 2660 |
|
|
2020
Q2 | $741K | Sell |
17,856
-79,068
| -82% | -$3.28M | ﹤0.01% | 2099 |
|
|
2020
Q1 | $2.78M | Sell |
96,924
-11,495
| -11% | -$330K | ﹤0.01% | 1163 |
|
|
2019
Q4 | $7.83M | Buy |
108,419
+72,410
| +201% | +$5.23M | ﹤0.01% | 957 |
|
|
2019
Q3 | $5.05M | Buy |
36,009
+17,075
| +90% | +$2.4M | ﹤0.01% | 1087 |
|
|
2019
Q2 | $3.47M | Buy |
18,934
+16,856
| +811% | +$3.09M | ﹤0.01% | 1354 |
|
|
2019
Q1 | $330K | Sell |
2,078
-42,510
| -95% | -$6.75M | ﹤0.01% | 2806 |
|
|
2018
Q4 | $4.27M | Buy |
44,588
+31,973
| +253% | +$3.06M | ﹤0.01% | 988 |
|
|
2018
Q3 | $1.78M | Sell |
12,615
-48,862
| -79% | -$6.9M | ﹤0.01% | 1863 |
|
|
2018
Q2 | $9.62M | Buy |
61,477
+51,480
| +515% | +$8.06M | 0.01% | 747 |
|
|
2018
Q1 | $1.61M | Sell |
9,997
-194,333
| -95% | -$31.3M | ﹤0.01% | 1501 |
|
|
2017
Q4 | $33.7M | Buy |
204,330
+172,037
| +533% | +$28.3M | 0.03% | 350 |
|
|
2017
Q3 | $2.01M | Sell |
32,293
-148,462
| -82% | -$9.25M | ﹤0.01% | 1234 |
|
|
2017
Q2 | $14.4M | Buy |
180,755
+179,524
| +14,584% | +$14.3M | 0.02% | 431 |
|
|
2017
Q1 | $88K | Sell |
1,231
-66,873
| -98% | -$4.78M | ﹤0.01% | 2888 |
|
|
2016
Q4 | $3.48M | Buy |
68,104
+67,682
| +16,038% | +$3.45M | ﹤0.01% | 893 |
|
|
2016
Q3 | $19K | Sell |
422
-47,909
| -99% | -$2.16M | ﹤0.01% | 3058 |
|
|
2016
Q2 | $1.46M | Buy |
48,331
+45,937
| +1,919% | +$1.38M | ﹤0.01% | 1253 |
|
|
2016
Q1 | $77K | Buy |
2,394
+1,823
| +319% | +$58.6K | ﹤0.01% | 2402 |
|
|
2015
Q4 | $33K | Sell |
571
-11,717
| -95% | -$677K | ﹤0.01% | 2587 |
|
|
2015
Q3 | $516K | Buy |
12,288
+10,632
| +642% | +$446K | ﹤0.01% | 1714 |
|
|
2015
Q2 | $121K | Buy |
1,656
+1,185
| +252% | +$86.6K | ﹤0.01% | 2288 |
|
|
2015
Q1 | $24K | Sell |
471
-96
| -17% | -$4.89K | ﹤0.01% | 3039 |
|
|
2014
Q4 | $21K | Buy |
+567
| New | +$21K | ﹤0.01% | 3417 |
|